Article
Therapeutic complications in a patient with high-risk acute lymphoblastic leukemia and undiagnosed hereditary hemochromatosis.
Pediatric blood & cancer - 1 Jan 2012
Balagtas Jay Michael S, Dahl Gary V
Abstract excerpt
Hereditary hemochromatosis (HH) is an autosomal-recessive disorder of iron metabolism that most commonly manifests in the fourth or fifth decade of life. Here, we describe a 14-year-old male who presented with high-risk acute lymphoblastic leukemia and previously undiagnosed HH. His treatment course was remarkable for significant therapeutic complications, including iron overload, hepatic failure, cardiac...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
